Overall , both forms of preventive light therapy reduced the incidence of SAD numerically compared with no light therapy .
BACKGROUND Seasonal affective disorder ( SAD ) is a seasonal pattern of recurrent major depressive episodes that most commonly occurs during autumn or winter and remits in spring .
The prevalence of SAD ranges from 1.5 % to 9 % , depending on latitude .
The predictable seasonal aspect of SAD provides a promising opportunity for prevention .
This review - one of four review s on efficacy and safety of interventions to prevent SAD - focuses on light therapy as a preventive intervention .
Light therapy is a non-pharmacological treatment that exposes people to artificial light .
Mode of delivery ( e.g. visors , light boxes ) and form of light ( e.g. bright white light ) vary .
OBJECTIVES To assess the efficacy and safety of light therapy ( in comparison with no treatment , other types of light therapy , second-generation antidepressants , melatonin , agomelatine , psychological therapies , lifestyle interventions and negative ion generators ) in preventing SAD and improving patient-centred outcomes  among adults with a history of SAD .
Morning or night-time melatonin is ineffective in seasonal affective disorder.
Melatonin , at the same doses used to treat circadian-rhythm related sleep disturbances , had no effect on the depressive symptoms in seasonal affective disorder ( SAD ) patients , whether given early ( 7 a.m. ) or late ( 11 p.m. ) for a week . Slight improvements in sleep were seen with nighttime administration . The circadian rhythmicity of urinary 6-sulphatoxymelatonin was not modified in any way . Melatonin at this dosage ( 5 mg/day ) or at these two times is therefore not a potential alternative treatment for SAD ; light remains the therapy of choice
Overall , both forms of preventive light therapy reduced the incidence of SAD numerically compared with no light therapy .
BACKGROUND Seasonal affective disorder ( SAD ) is a seasonal pattern of recurrent major depressive episodes that most commonly occurs during autumn or winter and remits in spring .
The prevalence of SAD ranges from 1.5 % to 9 % , depending on latitude .
The predictable seasonal aspect of SAD provides a promising opportunity for prevention .
This review - one of four review s on efficacy and safety of interventions to prevent SAD - focuses on light therapy as a preventive intervention .
Light therapy is a non-pharmacological treatment that exposes people to artificial light .
Mode of delivery ( e.g. visors , light boxes ) and form of light ( e.g. bright white light ) vary .
OBJECTIVES To assess the efficacy and safety of light therapy ( in comparison with no treatment , other types of light therapy , second-generation antidepressants , melatonin , agomelatine , psychological therapies , lifestyle interventions and negative ion generators ) in preventing SAD and improving patient-centred outcomes  among adults with a history of SAD .